Ae. Moses et al., RELATIVE CONTRIBUTIONS OF HYALURONIC-ACID CAPSULE AND M-PROTEIN TO VIRULENCE IN A MUCOID STRAIN OF THE GROUP-A STREPTOCOCCUS, Infection and immunity, 65(1), 1997, pp. 64-71
The antiphagocytic effect of M protein has been considered a critical
element in virulence of the group A streptococcus. The hyaluronic acid
capsule also appears to play an important role: studies of an acapsul
ar mutant derived from the mucoid or highly encapsulated M protein typ
e 18 group A streptococcal strain 282 indicated that loss of capsule e
xpression was associated with decrease resistance to phagocytic killin
g and with reduced virulence in mice. To study directly the relative c
ontributions to virulence of M protein and the hyaluronic acid capsule
in strain 282, we inactivated the gene encoding the M protein (emm18)
both in wild-type strain 282 and in its acapsular mutant, strain TX72
. Inactivation of emm18 was accomplished by integrational plasmid muta
genesis, using the temperature-sensitive shuttle vector pJRS233 harbor
ing a 5' DNA segment of emm18. As reported previously, wild-type strai
n 282 was resistant to phagocytic killing in vitro, both in whole huma
n blood and in 10% serum. The capsule mutant TX72 was highly susceptib
le to phagocytic killing in 10% serum. The capsule mutant TX72 was hig
hly susceptible to phagocytic killing in 10% serum. The double mutant
TX74 was sensitive to killing in both conditions. In a mouse infection
model, the 50% lethal dose was increased by 60- adn 80-fold for the c
apsule and double mutants, respectively, compared with that of strain
282, but only by 6-fold for the M protein mutant. Integration of the s
train 282 capsule genes into the chromosome of a nonmucoid M1 strain r
esulted in high-level capsule production and rendered the transformed
strain resistant to phagocytic killing in 10% serum. These results pro
vide further evidence that the hyaluronic acid capsule confers resista
nce tp phagocytosis and enhances group A streptococcal virulence. The
results suggest also that assessment of in vitro resistance to phagocy
tosis in 10% serum rather than in whole blood may be a more accurate r
eflection of virulence in vivo of group A streptococci.